Found 177 matching trials
Investigation of Medical Management to Prevent Episodes of Diverticulitis Trial NA This is a randomized trial (n=75) of a Mediterranean style Food Pattern and...
Show More Location
Harborview Medical Center
Learn More & Join Trial
Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors PHASE1 LErafAON is a liposome encapsulated c-raf antisense oligonucleotide. Raf-1 ...
Show More Location
Georgetown University
Learn More & Join Trial
Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors PHASE1 This is a 2-part Phase 1b study of BGB-283 (lifirafenib) and PD-0325901 (mi...
Show More Location
University of California Los Angeles
Learn More & Join Trial
FOLFOX-HAIC as Conversion Treatment for Initially Unresectable Colorectal Liver Metastasis PHASE2 Try FOLFOX-HAIC combining bevacizumab or cetuximab for initially unresectab...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma PHASE1 RATIONALE: Sorafenib and everolimus may stop the growth of cancer cells by ...
Show More Location
Holden Comprehensive Cancer Center at University of Iowa
Learn More & Join Trial
Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease PHASE2 Erdheim-Chester Diseases (ECD) is a very rare non-Langerhans cell histiocyt...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Laser Assisted Treatment of Fistula In Ano NA Randomised Controlled Trial comparing Laser assisted closure of transsphinc...
Show More Location
Antwerp University Hospital
Learn More & Join Trial
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs PHASE2 This is a prospective non-randomized national clinical phase 2 trial that a...
Show More Location
Turku University Hospital Cancer Centre
Learn More & Join Trial
Sorafenib and Bortezomib in Treating Patients With Advanced Cancer PHASE1 This phase I trial is studying the side effects and best dose of sorafenib ...
Show More Learn More & Join Trial
Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular Carcinoma PHASE2 This is a single arm, nonrandomized, single center clinical study to invest...
Show More Learn More & Join Trial